肝癌214例介入治疗的并发症观察及防治体会

目的 :观察和分析中晚期肝癌经导管肝动脉灌注化疗栓塞治疗的并发症与防治。方法 :对 2 14例 3 80次介入治疗出现的并发症进行了详细观察、记录和分析。结果 :2 14例 3 80次介入治疗出现并发症有 :发热 3 12次 ( 3 12 /3 80 ) ,腹痛 2 0 2次 ( 2 0 2 /3 80 ) ,肝功异常或腹水 12 6次 ( 12 6/3 80 ) ,顽固性呃逆 16次 ( 16/3 80 ) ,及股动脉穿刺部位出血 4次 ,应激性溃疡 4次 ,另外 2 14例中因持续肝功异常及重度黄疸死亡 5例。结论 :施术者技术的细致与熟练 ,应用抗癌药的种类与量适当、尽量行超选插管以及术前、术后辅助治疗准备充分 ,可最大限度减少并发症的发生。

中晚期肝癌介入术中应用明胶海绵时机的探讨

目的探讨肝癌肝动脉栓塞应用明胶海绵的时机。方法回顾120例肝癌患者在介入治疗中肝肿瘤的情况,就首次介入术中是否应用明胶海绵栓塞作一讨论和比较。结果在首次治疗操作过程中,对肿瘤较大、注入碘油抗癌药在肿瘤区域分布欠均匀时,仅以碘油抗癌药填充癌灶。待能够行第二次治疗时,用碘油抗癌药尽量充盈癌灶后,视病情加用明胶海绵颗粒栓塞的作法,可减少术后并发症,延长生存期。结论视病情而定掌握明胶海绵栓塞的时机,更有利于对肝癌肿瘤的控制,有效提高患者生存期。

Analysis of therapeutic efficacy of Aredia in treating pain caused by advanced malignant metastatic bone tumors

Objective To study therapeutic efficacy of Aredia in treating malignant metastatic bone tumors. Method 60～90 mg Aredia was administrated iv in 31 cases with malignant metastatic tumors,once each week. Results Pain in 12 cases was significantly relieved.14 cases acquired relif.Total effective rate was 83.9%.Activity ability was improved by 80.6%.No apparent toxicological and adverse effects as well as fever and cold symptoms were observed.Conclusion Aredia is a kind of ideal drugs for treatment of pain caused by malignant metastatic bone tumors.It is convenient in use and could be endured by patients.